Chapter 3 Market and Technology Background
- Description of Market Trends
- Asia-Pacific is an Emerging Market
- Market Drivers
- Opportunities
- Limitations and Challenges
Chapter 4 Market Breakdown by Product
- Solid Tumor Kits
- Multi-Marker Solid Tumor Panels
- Reagents
- Others (Microchips, Micro-Beads)
Chapter 5 Market Breakdown by End Use
- Academics
- Labs and Pathologies
- Companies (Biotechnology, Pharmaceutical and Contract Research Organization (CRO))
Chapter 6 Market Breakdown by Indication
- Non-Cancerous Tumor
- Prostate Cancer
- Colorectal Cancer
- Ovarian Cancer
- Breast Cancer
- Oral Cancer
- Lung Cancer
- Other Indications
- Lymphoma
- Thyroid Cancer
Chapter 7 Market Breakdown by Method
- Biomarkers
- Efflux Analysis of DNA
- Dye Exclusion Assays
- Others (Biopsy)
Chapter 8 Market Breakdown by Region
- North America
- United States
- Canada
- Europe
- United Kingdom
- Germany
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
- Rest of the World (RoW)
- Latin America
- Middle East and Africa (MEA)
Chapter 9 Patent Review/New Developments
- New Technologies for Cell Characterization and Isolation of Tumor Cells
- Evolution of Microfluidic Chips
- Laser Capture Microdissection
- Evolution of Nano-Velcro Cell-Affinity Assays
- Second-Generation Nano-Velcro-LMD Technology for Single-Tumor cell Isolation
- Micromanipulator
- Limiting Dilution
- New Product Developments
- Patent Analysis
Chapter 10 Analysis of Market Opportunities
- Key Suppliers and Manufacturers Positioning and Strategies
- AdipoGen Life Sciences
- Cayman Chemical
- NSJ Bioreagents
- AAT Bioquest
- Medical & Biological Laboratories Co., Ltd.
- Manufacturer Positioning
- Pfizer Corp.
- Thermo Fisher Scientific
- AstraZeneca
- Daiichi Sankyo
- Recent Activities
- R&D Activities
- AbbVie, Inc.
- Fluxion Biosciences
- Genmab A/S
- Onconova Therapeutics
Chapter 11 Company Profiles
- Abbvie, Inc.
- Abcodia Ltd.
- Astrazeneca
- Beckman Coulter
- Bio-Techne Corp.
- Cell Biolabs, Inc.
- Cynvenio Biosystems, Inc.
- Daiichi Sankyo
- Eisai Co. Ltd.
- Epizyme, Inc.
- Fluxion Biosciences, Inc.
- Genmab A/S
- Gilead Sciences, Inc.
- Glaxosmithkline Plc
- F. Hoffman-La Roche Ltd.
- Illumina, Inc.
- Janssen
- Juno Therapeutics, Inc.
- Lidds
- Merck
- Miltenyi Biotech
- MP Biomedicals
- Neogenomics
- Novocure
- Oncomed Pharmaceuticals, Inc.
- Onconova Therapeutics
- Perkinelmer, Inc.
- Pfizer, Inc.
- Propanc Biopharma, Inc.
- Psioxus Therapeutics Ltd.
- Regnix
- Seracare Lifesciences
- Taiho Pharma
- Takeda Pharmaceutical Co., Ltd.
- Tarveda Therapeutics
- Tesaro, Inc.
- Thermo Fisher Scientific
List of Tables
Summary Table: Global Market for Cell Separation and Characterization in Solid Tumors, by Product Type, Through 2023
Table 1: Use of Immunohistochemistry for Cancer Biomarker Assessment
Table 2: Application of FISH for the Study of Solid Tumors
Table 3: Manufacturers of Available PCR Instruments
Table 4: MACS Products, by Miltenyi Biotec, 2018
Table 5: Density Gradient Media Types and Their Principal Uses
Table 6: Selection Table
Table 7: Types of ATPS with Representative Examples
Table 8: Applicable Force Field and Corresponding FFF Techniques
Table 9: Microfluidic Methods for Cell Isolation
Table 10: Technologies Driving the Future of the Cancer Diagnostic Market
Table 11: Global Cancer Incidences, 2005 vs. 2015
Table 12: Number of MRI Machines, by Country, 2010 vs. 2015
Table 13: Number of CT Scanners, by Country, 2010 vs. 2015
Table 14: Number of Mammography Machines, by Country, 2010 vs. 2015
Table 15: List of Awareness Day Related to Cancer
Table 16: Biomarkers for Different Types of Cancer
Table 17: Cost of Prostate Cancer Treatment in India and the U.S., 2017
Table 18: Global Market for Cell Separation and Characterization in Solid Tumors, by Product Type, Through 2023
Table 19: Global Market for Solid Tumor Kits, by Region, Through 2023
Table 20: Thermo Fisher Scientific Solid Tumor Kit
Table 21: PerkinElmer Oncology and Solid Tumor Kit Specification
Table 22: Global Market for Multi-Marker Solid Tumor Panels, by Region, Through 2023
Table 23: Commercially Available Multi-Marker Solid Tumor Panels Using NGS
Table 24: Global Market for Reagents, by Region, Through 2023
Table 25: MLPA Solutions for Solid Tumors
Table 26: Global Market for Other Products, by Region, Through 2023
Table 27: Microbeads Offered, by Miltenyi Biotec
Table 28: Global Market for Cell Separation and Characterization in Solid Tumors, by End Use, Through 2023
Table 29: Global Market for Academics, by Region, Through 2023
Table 30: Major Research Institutes and the Solid Tumor Treatment Offered
Table 31: Global Market for Labs and Pathology, by Region, Through 2023
Table 32: Commonly Used Molecular Diagnostic Techniques
Table 33: Global Market for Companies, by Region, Through 2023
Table 34: Major Companies and their Product Portfolio
Table 35: Global Market for Cell Separation and Characterization in Solid Tumors, by Indication, Through 2023
Table 36: Global Market for Non-Cancerous Tumor, by Region, Through 2023
Table 37: Global Market for Prostate Cancer, by Region, Through 2023
Table 38: Global Market for Colorectal Cancer, by Region, Through 2023
Table 39: Colorectal Cancer Biomarkers
Table 40: Global Market for Ovarian Cancer, by Region, Through 2023
Table 41: Ovarian Carcinoma-Specific Over-Expressed Markers
Table 42: Global Market for Breast Cancer, by Region, Through 2023
Table 43: List of Biosimilars for Breast Cancer in Phase III Trials
Table 44: Global Market for Oral Cancer, by Region, Through 2023
Table 45: Global Market for Lung Cancer, by Region, Through 2023
Table 46: Clinically Relevant Biomarkers for Lung Cancer
Table 47: Global Market for Other Indications, by Region, Through 2023
Table 48: Global Market for Cell Separation and Characterization in Solid Tumor, by Method, Through 2023
Table 49: Global Market for Biomarkers, by Region, Through 2023
Table 50: Global Market for Efflux Analysis of DNA, by Region, Through 2023
Table 51: Global Market for Dye Exclusion Assays, by Region, Through 2023
Table 52: Global Market for Other Methods, by Region, Through 2023
Table 53: North American Market for Cell Separation and Characterization in Solid Tumor, by Product Type, Through, 2023
Table 54: North American Market for Cell Separation and Characterization in Solid Tumor, by End Use, Through 2023
Table 55: North American Market for Cell Separation and Characterization in Solid Tumor, by Indication, Through 2023
Table 56: North American Market for Cell Separation and Characterization in Solid Tumor, by Method, Through, 2023
Table 57: North American Market for Cell Separation and Characterization in Solid Tumor, by Country, Through 2023
Table 58: The U.S. Expenditures in Medical and Healthcare Research, 2013-2015
Table 59: Estimated New Cases and Fatalities of Cancer in the U.S., 2017
Table 60: Distribution of Projected New Cancer Cases in Canada, by Cancer Type, 2017
Table 61: Canadian Market for Investments Made in Cancer Research, by Organization, 2015
Table 62: European Market for Cell Separation and Characterization in Solid Tumor, by Product Type, Through 2023
Table 63: European Market for Cell Separation and Characterization in Solid Tumor, by End Use, Through 2023
Table 64: European Market for Cell Separation and Characterization in Solid Tumor, by Indication, Through 2023
Table 65: European Market for Cell Separation and Characterization in Solid Tumor, by Method, Through 2023
Table 66: European Market for Cell Separation and Characterization in Solid Tumor, by Country, Through 2023
Table 67: Twenty Most Common Cancer Diseases in the U.K., 2015
Table 68: Major Cancer Organizations in Germany
Table 69: Asia-Pacific Market for Cell Separation and Characterization in Solid Tumor, by Product Type, Through 2023
Table 70: Asia-Pacific Market for Cell Separation and Characterization in Solid Tumor, by End Use, Through 2023
Table 71: Asia-Pacific Market for Cell Separation and Characterization in Solid Tumor, by Indication, Through 2023
Table 72: Asia-Pacific Market for Cell Separation and Characterization in Solid Tumor, by Method, Through 2023
Table 73: Asia-Pacific Market for Cell Separation and Characterization in Solid Tumor, by Country, Through 2023
Table 74: Common Cancer Incidences in India, 2015
Table 75: Regional Cancer Centers in India
Table 76: Rest of World Market for Cell Separation and Characterization in Solid Tumor, by Product Type, Through 2023
Table 77: Rest of World Market for Cell Separation and Characterization in Solid Tumor, by End Use, Through 2023
Table 78: Rest of World Market for Cell Separation and Characterization in Solid Tumor, by Indication, Through 2023
Table 79: Rest of World Market for Cell Separation and Characterization in Solid Tumor, by Method, Through 2023
Table 80: Rest-of-World Market for Cell-Separation and Characterization in Solid Tumor, by Country, Through 2023
Table 81: Community Health Grant in Latin America
Table 82: Estimated Brazilian Cancer Incidences, by Gender, 2016
Table 83: Research Institutes in Middle East
Table 84: Research Institutes in Africa
Table 85: Some of the Urinary and Serological Proteomic Biomarkers Discovered in Prostate Cancer in a South African Cohort
Table 86: Comparison of All Cell Isolation Technologies
Table 87: Patent Analysis in Selected Countries for Global Cell Separation and Characterization in the Solid Tumor Market, by Category
Table 88: Number of Patents in Global Cell Separation and Characterization in the Solid Tumor Market, by Key Players, Jan. 2016-May 2018
Table 89: Patents Granted in Global Cell Separation and Characterization in Solid Tumor Market, Jan. 2016-May 2018
List of Figures
Summary Figure: Global Market for Cell Separation and Characterization in Solid Tumors, by Product Type, 2017-2023
Figure 1: Immunohistochemistry-Staining Method
Figure 2: Cell Sorting Machine
Figure 3: Common Diagnostic Tests Used for Cancer Diagnostic
Figure 4: Global Market Share of Personalized Medicine Under Development, 2016
Figure 5: Global Market Share of Oncology Personalized Medicine, 2016
Figure 6: Global Cancer Moon-Shot Budget Allocation, 2017-2023
Figure 7: UK Cancer Research Funding of Major Cancers, by Type, 2016-2017
Figure 8: APAC Countries Cancer Demographics, 2016
Figure 9: Biomarkers Used for Cell Separation and Characterization in Solid Tumors
Figure 10: North American Market Share in Healthcare Expenditure, by Country, 2016
Figure 11: Canadian Cancer Facts, 2017
Figure 12: Canadian Market Share for Investments Made for Cancer Research, by Organization Type, 2015
Figure 13: Cancer Mortalities in the U.K., 2011-2017
Figure 14: Cancer Mortalities in Germany, 2011-2017
Figure 15: Prevalence of Breast Cancer in Germany, 2018
Figure 16: Cancer Mortalities in France, 2011-2017
Figure 17: Spanish Population Share, by Age Structure, 2017
Figure 18: Cancer Mortalities in Spain, 2011-2017
Figure 19: Cancer Mortalities in Italy, 2011-2017
Figure 20: Rest of the European Countries with High Cancer Mortalities, 2014
Figure 21: Chinese Expenditure in Healthcare Research, 2016
Figure 22: Cancer Mortalities in Japan, 2010-2014
Figure 23: Population Aged 65 and Above in Japan, 2013-2016
Figure 24: Conventional Solid Tumor Isolation Techniques
Figure 25: Product Developments During, 2017-2018
